Abstract Purpose: No studies extensively compared the young adults (YA, 18e39 years), middle-aged (40e69 year
Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients...
Soft tissue sarcoma is one of the commonest orthopaedic related malignancy. Approximately 80% of sa...
Several patient demographic factors, including marital status, have been demonstrated to have progno...
Purpose: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 year...
PURPOSE: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 year...
Nearly half of soft-tissue sarcoma (STS) patients are over the age of 65, and the behavior of cancer...
Background: The population of many countries is aging and a significant number of elderly patients w...
BACKGROUND:Almost half of patients diagnosed with soft tissue sarcoma (STS) are older than 65 years;...
Background: In recent years, there has been growing awareness of the distinct characteristics of ado...
BackgroundRadiation therapy (RT) is a standard component in the multimodality management of localize...
Background Sarcomas are rare, heterogeneous tumours affecting patients of any age. Previous surveys ...
Purpose: Soft tissue sarcomas (STS) account for 8% of all cancers in adolescents and young adults (A...
Purpose: Soft tissue sarcomas (STS) account for 8% of all cancers in adolescents and young adults (A...
Survival outcomes for adolescent and young adult patients with soft tissue sarcomas lag behind those...
Contains fulltext : 200566.pdf (publisher's version ) (Open Access)BACKGROUND: Sar...
Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients...
Soft tissue sarcoma is one of the commonest orthopaedic related malignancy. Approximately 80% of sa...
Several patient demographic factors, including marital status, have been demonstrated to have progno...
Purpose: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 year...
PURPOSE: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 year...
Nearly half of soft-tissue sarcoma (STS) patients are over the age of 65, and the behavior of cancer...
Background: The population of many countries is aging and a significant number of elderly patients w...
BACKGROUND:Almost half of patients diagnosed with soft tissue sarcoma (STS) are older than 65 years;...
Background: In recent years, there has been growing awareness of the distinct characteristics of ado...
BackgroundRadiation therapy (RT) is a standard component in the multimodality management of localize...
Background Sarcomas are rare, heterogeneous tumours affecting patients of any age. Previous surveys ...
Purpose: Soft tissue sarcomas (STS) account for 8% of all cancers in adolescents and young adults (A...
Purpose: Soft tissue sarcomas (STS) account for 8% of all cancers in adolescents and young adults (A...
Survival outcomes for adolescent and young adult patients with soft tissue sarcomas lag behind those...
Contains fulltext : 200566.pdf (publisher's version ) (Open Access)BACKGROUND: Sar...
Background: To assess changes in survival over time of extremity soft tissue sarcoma (ESTS) patients...
Soft tissue sarcoma is one of the commonest orthopaedic related malignancy. Approximately 80% of sa...
Several patient demographic factors, including marital status, have been demonstrated to have progno...